4 completed, 1 active not recruiting, 1 terminated, 1 withdrawn. 7 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 4, Active not recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Torulopsis: new trials by email Literature Review of Torulopsis trials Research Report on Torulopsis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus. Clobetasol Propionate, Placebo/Klobetasol APL oral gel 0.025%, Placebo - Oral Lichen Planus | Phase 2 / Phase 3 | Active not recruiting | Malmö University | 90 | 2020-05-18 | 2024-12-04 |
| Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis NDV-3A, NDV-3, Placebo - Vulvovaginal Candidiasis | Phase 1 / Phase 2 | Completed | NovaDigm Therapeutics, Inc. | 188 | 2013-07-01 | 2018-07-18 |
| Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment Normal Saline, anidulafungin - Ventilator Associated Pneumonia, Respiratory Tract Infection | Phase 2 | Terminated | Daren K. Heyland | 61 | 2010-04-01 | 2021-02-01 |
| Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis Comparing to Traditional Treatment of Troches Clotrimazole varnish, Clotrimazole troches - Oral Candidiasis, Denture Stomatitis | Phase 2 | Completed | Hadassah Medical Organization | 13 | 2009-03-01 | 2015-03-25 |
| Effect of Fluconazole on the Levels of ASCA After Surgical Resection for Crohn's Disease. Fluconazole, Placebo - Crohn's Disease Aggravated | Phase 2 | Completed | University Hospital, Lille | 35 | 2008-07-01 | 2026-04-21 |
| A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Proven Candidaemia hLF1-11, Placebo - Candidaemia | Phase 1 / Phase 2 | Withdrawn | AM-Pharma | 2008-07-01 | 2015-06-30 | |
| Itraconazole for the Prevention of Fungal Infections in Chronic Granulomatous Disease itraconazole - Mycoses | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 100 | 1991-01-01 | 2008-03-04 |
Aspergillosis (1) · Candidemia (1) · Candidiasis, Oral (1) · Candidiasis, Vulvovaginal (1) · Crohn Disease (1) · Granulomatous Disease, Chronic (1) · Lichen Planus, Oral (1) · Mycoses (1) · Pneumonia, Ventilator-Associated (1) · Respiratory Tract Infections (1) · Stomatitis, Denture (1)
Infections (5) · Bacterial Infections and Mycoses (4) · Candidiasis (3) · Mycoses (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Disease Attributes (2) · Mouth Diseases (2) · Stomatognathic Diseases (2) · Candidiasis, Invasive (1) · Chronic Disease (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cross Infection (1) · Digestive System Diseases (1) · Female Urogenital Diseases (1)
Anidulafungin (1) · Clobetasol (1) · Fluconazole (1) · Itraconazole (1) · Saline Solution (1) · lactoferrin (1-11), human (1)
AM-Pharma (1) · Daren K. Heyland (1) · Hadassah Medical Organization (1) · Malmö University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · NovaDigm Therapeutics, Inc. (1) · University Hospital, Lille (1)
United States (2) · Canada (1) · France (1) · Israel (1) · Netherlands (1) · Sweden (1)
Daren Heyland, MD (1) · John P. Hennessey, Jr., Ph.D. (1) · Pierre Desreumaux, MD, PhD (1) · Professor P.E. Verweij, MD, PhD (1) · Rakefet Czerninski, DMD (1)
PMID 21287306, PMID 24981955, PMID 29697768, PMID 33922391, PMID 42163196
2008 (1)